1982

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.
Hepatology. 1981 Sep-Oct;1(5):377-85. Unique Identifier : AIDSLINE MED/82074223
Szmuness W; Stevens CE; Zang EA; Harley EJ; Kellner A
A controlled, randomized, double-blind trial in 1,083 homosexual men from New York confirmed that a highly purified, formalin-inactivated vaccine against hepatitis B prepared from HBsAg positive plasma, is safe immunogenic, and highly efficacious. Over 95% of vaccinated subjects developed antibody against the surface


Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Can Med Assoc J. 1981 Oct 15;125(8):845-9. Unique Identifier : AIDSLINE MED/82069908
Joncas JH; Wills A; Reece E; Fox Z
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
Cancer Res. 1981 Nov;41(11 Pt 1):4237-42. Unique Identifier : AIDSLINE MED/82070026
Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
Tissues from patients thought to have Epstein-Barr virus (EBV)-induced lymphoproliferative diseases were probed for EBV genomes using 2 independent hybridization techniques. Tissues from six patients with the X-linked lymphoproliferative syndrome, all five renal allograft recipients with immunoblastic sarcoma, and eig


Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency.
Cancer Res. 1981 Nov;41(11 Pt 1):4243-7. Unique Identifier : AIDSLINE MED/82070027
Reece ER; Gartner JG; Seemayer TA; Joncas JH; Pagano JS
A fatal disseminated polyclonal malignant lymphoproliferative disorder of B-cells (immunoblastic sarcoma) developed shortly after a second thymic epithelial peritoneal implant in a 5-yr-old girl with combined immunodeficiency. The immunodeficiency was characterized by low T-cell numbers and function, very low levels o


Identification of a 20,000-dalton protein in SSV-transformed nonproducer cells.
Virology. 1981 Dec;115(2):401-5. Unique Identifier : AIDSLINE MED/82086161
Thiel HJ; Matthews TJ; Weinhold KJ; Broughton EM
Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain.
Lancet. 1981 Nov 21;2(8256):1156-9. Unique Identifier : AIDSLINE MED/82079588
Viola LA; Barrison IG; Coleman JC; Paradinas FJ; Fluker JL; Evans BA; Murray-Lyon IM
100 consecutive British chronic carriers of hepatitis B surface antigen seen in a London teaching hospital are described. 77 were male homosexuals and only 19 had either symptoms or signs of chronic liver disease. 27 had normal liver function tests and 69 of the remaining patients had minimal changes, chronic persiste


Immunocompromised homosexuals [editorial]
Lancet. 1981 Dec 12;2(8259):1325-6. Unique Identifier : AIDSLINE MED/82079721
Gay compromise syndrome [letter]
Lancet. 1981 Dec 12;2(8259):1338-9. Unique Identifier : AIDSLINE MED/82079727
Brennan RO; Durack DT
Primary Pneumocystis carinii and cytomegalovirus infections [letter]
Lancet. 1981 Dec 12;2(8259):1339. Unique Identifier : AIDSLINE MED/82079728
du Bois RM; Branthwaite MA; Mikhail JR; Batten JC

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 1982. AEGiS.